Several other equities research analysts have also weighed in on MDSO. Royal Bank Of Canada reiterated a hold rating and issued a $80.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Zacks Investment Research lowered shares of Medidata Solutions from a hold rating to a sell rating in a report on Thursday. Wells Fargo & Company cut their target price on shares of Medidata Solutions from $83.00 to $80.00 and set a market perform rating on the stock in a report on Friday, October 27th. SunTrust Banks, Inc. reiterated a buy rating and issued a $92.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Finally, Jefferies Group LLC reiterated a hold rating and issued a $78.00 target price on shares of Medidata Solutions in a report on Tuesday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus target price of $84.25.
Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Thursday, October 26th. The company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.02. The company had revenue of $140.08 million for the quarter, compared to analyst estimates of $141.27 million. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period last year, the business posted $0.28 earnings per share.
TRADEMARK VIOLATION NOTICE: “Medidata Solutions, Inc. (MDSO) Now Covered by Analysts at Dougherty & Co” was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://www.com-unik.info/2017/11/02/medidata-solutions-inc-mdso-now-covered-by-analysts-at-dougherty-co.html.
In related news, COO Michael L. Capone sold 5,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total value of $372,650.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 5.80% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in MDSO. Canada Pension Plan Investment Board lifted its stake in Medidata Solutions by 2,994.6% in the third quarter. Canada Pension Plan Investment Board now owns 1,151,200 shares of the company’s stock valued at $89,863,000 after acquiring an additional 1,114,000 shares during the last quarter. American Century Companies Inc. lifted its stake in Medidata Solutions by 610.9% in the third quarter. American Century Companies Inc. now owns 1,186,843 shares of the company’s stock valued at $92,645,000 after acquiring an additional 1,019,883 shares during the last quarter. State Street Corp lifted its stake in Medidata Solutions by 27.7% in the second quarter. State Street Corp now owns 1,828,913 shares of the company’s stock valued at $143,022,000 after acquiring an additional 396,793 shares during the last quarter. Voya Investment Management LLC lifted its stake in Medidata Solutions by 1,571.0% in the second quarter. Voya Investment Management LLC now owns 376,259 shares of the company’s stock valued at $29,423,000 after acquiring an additional 353,742 shares during the last quarter. Finally, Teachers Advisors LLC lifted its stake in Medidata Solutions by 254.0% in the first quarter. Teachers Advisors LLC now owns 371,554 shares of the company’s stock valued at $21,435,000 after acquiring an additional 266,606 shares during the last quarter. Hedge funds and other institutional investors own 98.49% of the company’s stock.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
What are top analysts saying about Medidata Solutions Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medidata Solutions Inc. and related companies.